191 related articles for article (PubMed ID: 15993539)
21. Notch-1 immunoexpression is increased in Alzheimer's and Pick's disease.
Nagarsheth MH; Viehman A; Lippa SM; Lippa CF
J Neurol Sci; 2006 May; 244(1-2):111-6. PubMed ID: 16473372
[TBL] [Abstract][Full Text] [Related]
22. Distribution of altered hippocampal neurons and axons immunoreactive with antisera against neuropeptide Y in Alzheimer's-type dementia.
Chan-Palay V; Lang W; Haesler U; Köhler C; Yasargil G
J Comp Neurol; 1986 Jun; 248(3):376-94. PubMed ID: 3522663
[TBL] [Abstract][Full Text] [Related]
23. Altered expression of COX-2 in subdivisions of the hippocampus during aging and in Alzheimer's disease: the Hisayama Study.
Fujimi K; Noda K; Sasaki K; Wakisaka Y; Tanizaki Y; Iida M; Kiyohara Y; Kanba S; Iwaki T
Dement Geriatr Cogn Disord; 2007; 23(6):423-31. PubMed ID: 17457030
[TBL] [Abstract][Full Text] [Related]
24. Spatial and temporal relationships between plaques and tangles in Alzheimer-pathology.
Schönheit B; Zarski R; Ohm TG
Neurobiol Aging; 2004 Jul; 25(6):697-711. PubMed ID: 15165691
[TBL] [Abstract][Full Text] [Related]
25. Hippocampal neurons in pre-clinical Alzheimer's disease.
West MJ; Kawas CH; Stewart WF; Rudow GL; Troncoso JC
Neurobiol Aging; 2004 Oct; 25(9):1205-12. PubMed ID: 15312966
[TBL] [Abstract][Full Text] [Related]
26. Laser microprobe analysis of brain aluminum in Alzheimer's disease.
Lovell MA; Ehmann WD; Markesbery WR
Ann Neurol; 1993 Jan; 33(1):36-42. PubMed ID: 8257483
[TBL] [Abstract][Full Text] [Related]
27. Calcium-binding protein secretagogin-expressing neurones in the human hippocampus are largely resistant to neurodegeneration in Alzheimer's disease.
Attems J; Preusser M; Grosinger-Quass M; Wagner L; Lintner F; Jellinger K
Neuropathol Appl Neurobiol; 2008 Feb; 34(1):23-32. PubMed ID: 17961140
[TBL] [Abstract][Full Text] [Related]
28. Cognitive impact of neuronal pathology in the entorhinal cortex and CA1 field in Alzheimer's disease.
von Gunten A; Kövari E; Bussière T; Rivara CB; Gold G; Bouras C; Hof PR; Giannakopoulos P
Neurobiol Aging; 2006 Feb; 27(2):270-7. PubMed ID: 16399212
[TBL] [Abstract][Full Text] [Related]
29. 14-3-3 proteins and zeta isoform containing neurofibrillary tangles in patients with Alzheimer's disease.
Umahara T; Uchihara T; Tsuchiya K; Nakamura A; Iwamoto T; Ikeda K; Takasaki M
Acta Neuropathol; 2004 Oct; 108(4):279-86. PubMed ID: 15235803
[TBL] [Abstract][Full Text] [Related]
30. Elevated expression of a regulator of the G2/M phase of the cell cycle, neuronal CIP-1-associated regulator of cyclin B, in Alzheimer's disease.
Zhu X; McShea A; Harris PL; Raina AK; Castellani RJ; Funk JO; Shah S; Atwood C; Bowen R; Bowser R; Morelli L; Perry G; Smith MA
J Neurosci Res; 2004 Mar; 75(5):698-703. PubMed ID: 14991845
[TBL] [Abstract][Full Text] [Related]
31. AMPA-selective glutamate receptor subtype immunoreactivity in the hippocampal formation of patients with Alzheimer's disease.
Ikonomovic MD; Sheffield R; Armstrong DM
Hippocampus; 1995; 5(5):469-86. PubMed ID: 8773259
[TBL] [Abstract][Full Text] [Related]
32. Aluminum in hippocampal neurons from humans with Alzheimer's disease.
Walton JR
Neurotoxicology; 2006 May; 27(3):385-94. PubMed ID: 16458972
[TBL] [Abstract][Full Text] [Related]
33. Transneuronally altered dendritic processing of tangle-free neurons in Alzheimer's disease.
Ohm TG; Münch S; Schönheit B; Zarski R; Nitsch R
Acta Neuropathol; 2002 May; 103(5):437-43. PubMed ID: 11935258
[TBL] [Abstract][Full Text] [Related]
34. Beta-protein/A4 deposits are not associated with hyperphosphorylated tau in somatostatin neurons in the hypothalamus of Alzheimer's disease patients.
van de Nes JA; Konermann S; Nafe R; Swaab DF
Acta Neuropathol; 2006 Feb; 111(2):126-38. PubMed ID: 16456666
[TBL] [Abstract][Full Text] [Related]
35. Immunopositivity for ESCRT-III subunit CHMP2B in granulovacuolar degeneration of neurons in the Alzheimer's disease hippocampus.
Yamazaki Y; Takahashi T; Hiji M; Kurashige T; Izumi Y; Yamawaki T; Matsumoto M
Neurosci Lett; 2010 Jun; 477(2):86-90. PubMed ID: 20420883
[TBL] [Abstract][Full Text] [Related]
36. CA1 hippocampal neuronal loss in familial Alzheimer's disease presenilin-1 E280A mutation is related to epilepsy.
Velez-Pardo C; Arellano JI; Cardona-Gomez P; Jimenez Del Rio M; Lopera F; De Felipe J
Epilepsia; 2004 Jul; 45(7):751-6. PubMed ID: 15230697
[TBL] [Abstract][Full Text] [Related]
37. Enhanced expression of 14-3-3 proteins in reactive astrocytes in Creutzfeldt-Jakob disease brains.
Kawamoto Y; Akiguchi I; Jarius C; Budka H
Acta Neuropathol; 2004 Oct; 108(4):302-8. PubMed ID: 15235801
[TBL] [Abstract][Full Text] [Related]
38. Aberrant localization of MAP5 immunoreactivity in the hippocampal formation in Alzheimer's disease.
Geddes JW; Lundgren K; Kim YK
J Neurosci Res; 1991 Sep; 30(1):183-91. PubMed ID: 1795403
[TBL] [Abstract][Full Text] [Related]
39. Differential neuronal expression of manganese superoxide dismutase in Alzheimer's disease.
Marcus DL; Strafaci JA; Freedman ML
Med Sci Monit; 2006 Jan; 12(1):BR8-14. PubMed ID: 16369462
[TBL] [Abstract][Full Text] [Related]
40. Functional alterations in Alzheimer's disease: diminution of cytochrome oxidase in the hippocampal formation.
Simonian NA; Hyman BT
J Neuropathol Exp Neurol; 1993 Nov; 52(6):580-5. PubMed ID: 8229076
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
